Advertisement
Home Tags Psoriasis

Tag: Psoriasis

Psoriasis is associated with an increased risk for cardiovascular interventions in patients with hypertension

Hypertension With Psoriasis Tied to More Cardiac Interventions

0
In patients with hypertension, psoriasis linked to increased risk for cardiovascular procedures, surgeries
Depending on the definition used

Classification of Psoriasis Severity Depends on Definition

0
Authors call for international standardization defining moderate-to-severe psoriasis
Recommendations have been developed for pharmacologic and nonpharmacologic treatment of psoriatic arthritis; the evidence-based guideline was published online Nov. 30 in Arthritis & Rheumatology.

Recommendations Developed for Psoriatic Arthritis Treatment

0
Guideline includes use of treat-to-target strategy for all adult patients with active PsA
Cardiovascular risk should be carefully evaluated in patients with psoriatic arthritis

Higher Cardiovascular Risk Seen With Psoriatic Arthritis

0
Risk seems to be increased especially in patients with a high inflammatory burden, late-onset psoriasis
A new scoring system that accounts for "not relevant" responses on the Dermatology Life Quality Index for patients with psoriasis is valid for avoiding bias and can improve access to biologics

Novel Scoring System Can Up Access to Biologics in Psoriasis

0
DLQI-R allows more patients to achieve threshold for becoming candidates for biologic treatment
Psoriasis appears to be significantly associated with inflammatory bowel disease

Psoriasis Linked to Increased Risk for Inflammatory Bowel Disease

0
Significant associations observed between psoriasis and risk for Crohn's disease, ulcerative colitis
Halobetasol propionate 0.01 percent lotion (BRYHALI Lotion) appears safe and effective for the treatment of moderate-to-severe plaque psoriasis

Halobetasol Propionate Lotion Shows Efficacy for Tx of Psoriasis

0
Findings based on two phase 3 trials of halobetasol propionate lotion versus vehicle
Selective inhibition of TYK2 with the oral agent BMS-986165 at doses of 3 mg daily and higher results in greater clearing of psoriasis versus placebo over 12 weeks

TYK2 Inhibitor Clears Psoriasis Over 12 Weeks

0
Findings seen in 12-week, phase 2 trial at oral doses over 3 mg daily
Some complementary and alternative medicines may be helpful in the treatment of psoriasis

Alternative Medicines May Aid in the Treatment of Psoriasis

0
Most studies evaluated fish oil, acupuncture, indigo naturalis, curcumin, meditation
Patients with severe psoriasis have low levels of adherence to the Mediterranean diet

Inverse Link for Mediterranean Diet Score, Severe Psoriasis

0
Significant inverse correlation between MEDI-LITE score and having severe psoriasis